Linagliptin Improves Insulin Sensitivity and Hepatic Steatosis in Diet-Induced Obesity

Open Access

Peer-reviewed

Research Article

Matthias Kern,

Affiliation Department of Medicine, University of Leipzig, Leipzig, Germany
⨯
Nora Klöting,

Affiliation IFB Obesity Diseases, Junior Research Group Animal Models, University of Leipzig, Leipzig, Germany
⨯
Heiko G. Niessen,

Affiliation Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
⨯
Leo Thomas,

Affiliation Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
⨯
Detlef Stiller,

Affiliation Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
⨯
Michael Mark,

Affiliation Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
⨯
Thomas Klein,

Affiliation Boehringer-Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
⨯
Matthias Blüher

* E-mail: bluma@medizin.uni-leipzig.de

Affiliation Department of Medicine, University of Leipzig, Leipzig, Germany
⨯

Reader Comments (0)

Fatty liver
Is the Subject Area "Fatty liver" applicable to this article?

Thanks for your feedback.
Adipose tissue
Is the Subject Area "Adipose tissue" applicable to this article?

Thanks for your feedback.
Diet
Is the Subject Area "Diet" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Lipids
Is the Subject Area "Lipids" applicable to this article?

Thanks for your feedback.
Blood sugar
Is the Subject Area "Blood sugar" applicable to this article?

Thanks for your feedback.
Magnetic resonance spectroscopy
Is the Subject Area "Magnetic resonance spectroscopy" applicable to this article?

Thanks for your feedback.